Show simple item record

dc.contributor.authorElkord, Eyad
dc.contributor.authorShablak, Alaaeldin
dc.contributor.authorStern, Peter L
dc.contributor.authorHawkins, Robert E
dc.date.accessioned2010-08-09T16:05:15Z
dc.date.available2010-08-09T16:05:15Z
dc.date.issued2009-12
dc.identifier.citation5T4 as a target for immunotherapy in renal cell carcinoma. 2009, 9 (12):1705-9 Expert Rev Anticancer Theren
dc.identifier.issn1744-8328
dc.identifier.pmid19954280
dc.identifier.doi10.1586/era.09.152
dc.identifier.urihttp://hdl.handle.net/10541/109310
dc.language.isoenen
dc.subjectCancerous Gene Expression Regulationen
dc.subjectKidney Canceren
dc.subject.meshAnimals
dc.subject.meshAntibodies, Monoclonal
dc.subject.meshCancer Vaccines
dc.subject.meshCarcinoma, Renal Cell
dc.subject.meshGene Expression Regulation, Neoplastic
dc.subject.meshHumans
dc.subject.meshImmunotherapy
dc.subject.meshKidney Neoplasms
dc.subject.meshMembrane Glycoproteins
dc.title5T4 as a target for immunotherapy in renal cell carcinoma.en
dc.typeArticleen
dc.identifier.journalExpert Review of Anticancer Therapyen


This item appears in the following Collection(s)

Show simple item record